South San Francisco, CA · Founded 2018 · Privately Held (backing)
Operator of a programmable cell therapy company intended to discover, develop, and commercialize curative immune cell therapies. ArsenalBio is based in South San Francisco, CA and was founded in 2018. Its last known valuation is $1.9 billion. It has raised $631 million.
Last price · $/share
—
Implied valuation
$1.9B
Total raised
$630.8M
Last round
—
Cap table — not yet on record
ArsenalBio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of ArsenalBio with a free account
·The complete investor list: 24 names
·Watch ArsenalBio: the Monday email on marks, rounds and moves
